- Home
- AQMS vs IBIO Comparison
AQMS vs IBIO Comparison
Compare AQMS & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- IBIO
- Stock Information
- Founded
- AQMS 2014
- IBIO 2008
- Country
- AQMS United States
- IBIO United States
- Employees
- AQMS N/A
- IBIO N/A
- Industry
- AQMS Metal Fabrications
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- AQMS Industrials
- IBIO Health Care
- Exchange
- AQMS Nasdaq
- IBIO Nasdaq
- Market Cap
- AQMS 11.1M
- IBIO 9.3M
- IPO Year
- AQMS 2015
- IBIO N/A
- Fundamental
- Price
- AQMS $0.76
- IBIO $0.98
- Analyst Decision
- AQMS Strong Buy
- IBIO Strong Buy
- Analyst Count
- AQMS 3
- IBIO 3
- Target Price
- AQMS $21.00
- IBIO $4.87
- AVG Volume (30 Days)
- AQMS 197.1K
- IBIO 452.8K
- Earning Date
- AQMS 08-04-2025
- IBIO 05-02-2025
- Dividend Yield
- AQMS N/A
- IBIO N/A
- EPS Growth
- AQMS N/A
- IBIO N/A
- EPS
- AQMS N/A
- IBIO N/A
- Revenue
- AQMS N/A
- IBIO $375,000.00
- Revenue This Year
- AQMS N/A
- IBIO $36.00
- Revenue Next Year
- AQMS $550.00
- IBIO N/A
- P/E Ratio
- AQMS N/A
- IBIO N/A
- Revenue Growth
- AQMS N/A
- IBIO 650.00
- 52 Week Low
- AQMS $0.73
- IBIO $0.64
- 52 Week High
- AQMS $8.20
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- AQMS 28.96
- IBIO 48.45
- Support Level
- AQMS $0.73
- IBIO $0.75
- Resistance Level
- AQMS $0.95
- IBIO $1.03
- Average True Range (ATR)
- AQMS 0.07
- IBIO 0.08
- MACD
- AQMS 0.01
- IBIO 0.08
- Stochastic Oscillator
- AQMS 8.61
- IBIO 75.74
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.